Answers are grounded in this paper and cite their sources.
People with hemophilia often experience chronic musculoskeletal pain, but invasive treatments are avoided due to bleeding risk. Extracorporeal shock wave therapy (ESWT) is widely used for refractory tendinopathies, yet its application in hemophilia is rarely reported. A 28-year-old man with severe hemophilia A and bilateral plantar fasciitis unresponsive to conservative therapy underwent focused ESWT after factor VIII replacement. Pain markedly improved after the first session and remained lower at 12 months without hemorrhagic complications. Low-to medium-energy ESWT for plantar fasciitis can be safely performed in people with hemophilia when adequate coagulation factor activity is maintained.
No takes yet. Share an insight, caveat, or question.
Seki et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: